Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Drugs Under Experimental and Clinical Research|January 1, 1989
Cefroxadine in the treatment of children affected by respiratory and ENT diseases. A multicentre study involving 1072 in-patientsF Scaglione, G Cattaneo, M M Bianchi, et al.International Journal of Obesity|January 1, 1986
Early improvement of left ventricular function during caloric restriction in obesityF Caviezel, A Margonato, G Slaviero, et al.Neuropediatrics|May 28, 2008
Different clinical and immunological presentation of ataxia-telangiectasia within the same familyA Soresina, A Meini, V Lougaris, et al.Tumori|June 30, 1991
Mitoxantrone as a single agent in pretreated metastatic breast cancer: effects on T lymphocyte subsets and their relation to clinical responseS Barni, P Lissoni, F Paolorossi, et al.Tumori|June 30, 1988
Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patientsP Lissoni, G Tancini, S Barni, et al.Journal of Chemotherapy (Florence, Italy)|June 1, 1990
Pathogen-host interactionF Fraschini, M Falchi, G Cattaneo, et al.AJNR. American Journal of Neuroradiology|September 27, 2014
Preclinical evaluation of the thrombogenicity and endothelialization of bare metal and surface-coated neurovascular stentsS Krajewski, B Neumann, J Kurz, et al.Anticancer Research|May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancerP Lissoni, S Barni, C Archili, et al.Circulation Research|July 27, 1999
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cellsC Banfi, L Mussoni, P Risé, et al.Anticancer Research|November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotensionP Lissoni, F Brivio, S Barni, et al.Pageof 12